Medinol Ltdis A Medical Technology Company Based In Israelspecializing In Cardiovascular Intervention Devicesfounded In December 1992The Company Employs Between 114 And 200 Individuals And Reported An Annual Revenue Of $63 Million In 2025Medinol Focuses On In House Researchdevelopmentand Manufacturing Of Advanced Medical Devicesensuring Full Control Over Its Processes The Company Is Well Known For Its Coronary And Peripheral Drug Eluting Stentsincluding The Elunir Stentand Has Delivered Over Two Million Stents Worldwidemedinol Is Also Developing Transcatheter Aortic Valve Replacement Technologies To Treat Heart Valve Diseases And Advancing Smart Physiological Monitoring Systems Through Its Subsidiarymicrotechthe Company Maintains A Strong Emphasis On Clinical Validation And Has A Robust Intellectual Property Portfolio To Protect Its Innovations
No conferences found for this company.
| Company Name | Medinol Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
